THE MATURATION OF DIFFERENTIATION THERAPY

[1] ANDREEFF M, IN PRESS BLOOD

[2] CASTAIGNE S, 1990, BLOOD, V76, P1704

[3] CASTAIGNE S, 1992, BLOOD, V79, P3110

[4] CHEN SJ, 1991, BLOOD, V78, P2696

[5] DIVERIO D, 1992, BLOOD, V79, P3331

[6] FRANCIS PA, 1992, P AN M AM SOC CLIN, V11, P108

[7] 13-CIS-RETINOIC ACID IN THE TREATMENT OF ORAL LEUKOPLAKIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) : 1501 - 1505

[8] PREVENTION OF 2ND PRIMARY TUMORS WITH ISOTRETINOIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (12) : 795 - 801

[9] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J]. BLOOD, 1988, 72 (02) : 567 - 572

[10] A CHARACTERISTIC PATTERN OF LEUKEMIC-CELL DIFFERENTIATION WITHOUT CYTOREDUCTION DURING REMISSION INDUCTION IN ACUTE PROMYELOCYTIC LEUKEMIA [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 793 - 798

[1] ANDREEFF M, IN PRESS BLOOD

[2] CASTAIGNE S, 1990, BLOOD, V76, P1704

[3] CASTAIGNE S, 1992, BLOOD, V79, P3110

[4] CHEN SJ, 1991, BLOOD, V78, P2696

[5] DIVERIO D, 1992, BLOOD, V79, P3331

[6] FRANCIS PA, 1992, P AN M AM SOC CLIN, V11, P108

[7] 13-CIS-RETINOIC ACID IN THE TREATMENT OF ORAL LEUKOPLAKIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) : 1501 - 1505

[8] PREVENTION OF 2ND PRIMARY TUMORS WITH ISOTRETINOIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (12) : 795 - 801

[9] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J]. BLOOD, 1988, 72 (02) : 567 - 572

[10] A CHARACTERISTIC PATTERN OF LEUKEMIC-CELL DIFFERENTIATION WITHOUT CYTOREDUCTION DURING REMISSION INDUCTION IN ACUTE PROMYELOCYTIC LEUKEMIA [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 793 - 798